Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts

Figure 1 Serial changes of liver function markers (total bilirubin, alanine aminotransferase, aspartate aminotransferase, international normalized ratio) in all patients after living donor liver transplantation. A: TB; B: ALT; C: AST; D: INR. No intergroup difference regarding postoperative levels of TB, ALT, AST and INR was obtained (P = 0.739, P = 0.631, P = 0.853, P = 0.570, respectively). TB: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; INR: International normalized ratio.

Figure 2 Cumulative 1-, 3- and 5-year graft survival rates. The cumulative graft survival rates were 82.22%, 71.11% and 71.11% in group A and 81.46%, 76.82% and 75.50% in group B, respectively (P = 0.623). aGRWR: Actuarial graft-to-recipient weight ratio